Preventing Sudden Cardiac Death: Can We Afford the Benefit?
- 19 April 2005
- journal article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 142 (8) , 664-666
- https://doi.org/10.7326/0003-4819-142-8-200504190-00015
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Faculty Opinions recommendation of Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.Published by H1 Connect ,2015
- Faculty Opinions recommendation of Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.Published by H1 Connect ,2015
- Clinical and Economic Implications of the Multicenter Automatic Defibrillator Implantation Trial-IIAnnals of Internal Medicine, 2005
- Prophylactic Use of an Implantable Cardioverter–Defibrillator after Acute Myocardial InfarctionNew England Journal of Medicine, 2004
- Evidence-Based Use of Cardiac Procedures and DevicesNew England Journal of Medicine, 2004
- Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trialsACC Current Journal Review, 2003
- Expanding indications for defibrillators after myocardial infarction: risk stratification and cost effectiveness.Cardiac Electrophysiology Review, 2003
- Effect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillatorAmerican Heart Journal, 2002
- Effectiveness and cost-effectiveness of implantable cardioverter defibrillators in the treatment of ventricular arrhythmias among medicare beneficiariesThe American Journal of Medicine, 2002
- Cost-effectiveness of the implantable cardioverter defibrillator?The Lancet, 2001